about
Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesisRanBPM interacts with psoriasin in vitro and their expression correlates with specific clinical features in vivo in breast cancer.S100A7 and the progression of breast cancerIdentification of new human coding steroid receptor RNA activator isoformsIncreasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotidesAltered expression of estrogen receptor-alpha variant messenger RNAs between adjacent normal breast and breast tumor tissues.The kinome associated with estrogen receptor-positive status in human breast cancerA bi-faceted role of estrogen receptor β in breast cancerAssay development for the determination of phosphorylation stoichiometry using multiple reaction monitoring methods with and without phosphatase treatment: application to breast cancer signaling pathwaysA framework for biobank sustainability.The mechanistic target for rapamycin pathway is related to the phosphorylation score for estrogen receptor-α in human breast tumors in vivo.Differential regulation of estrogen receptors α and β by 4-(E)-{(4-hydroxyphenylimino)-methylbenzene,1,2-diol}, a novel resveratrol analog.S100 proteins and their influence on pro-survival pathways in cancer.Steroid receptors in human breast tumorigenesis and breast cancer progression.Claudin 1 expression in basal-like breast cancer is related to patient ageCARM1 is an important determinant of ERα-dependent breast cancer cell differentiation and proliferation in breast cancer cells.A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancerNew insights into estrogen receptor function in human breast cancer.Immunohistochemical validation of multiple phospho-specific epitopes for estrogen receptor alpha (ERalpha) in tissue microarrays of ERalpha positive human breast carcinomasExpression of small breast epithelial mucin (SBEM) protein in tissue microarrays (TMAs) of primary invasive breast cancersIs oestrogen receptor-beta a predictor of endocrine therapy responsiveness in human breast cancer?Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours.Altered expression of exon 6 deleted progesterone receptor variant mRNA between normal human breast and breast tumour tissues.Oestrogen receptor-alpha variant mRNA expression in primary human breast tumours and matched lymph node metastasesRelationship of coregulator and oestrogen receptor isoform expression to de novo tamoxifen resistance in human breast cancerPotential role of estrogen receptor alpha (ERalpha) phosphorylated at Serine118 in human breast cancer in vivo.Targeting the EGFR pathway for cancer therapy.Estrogen receptor alpha negative breast cancer patients: estrogen receptor beta as a therapeutic target.Steroid Receptor RNA Activator Protein (SRAP): a potential new prognostic marker for estrogen receptor-positive/node-negative/younger breast cancer patientsThe relevance of phosphorylated forms of estrogen receptor in human breast cancer in vivo.Estrogen receptor variants in human breast cancer.Clinical significance of estrogen receptor phosphorylation.The role of estrogen receptor-β in breast cancer.Certification for biobanks: the program developed by the Canadian Tumour Repository Network (CTRNet).Intratumoural inflammation and endocrine resistance in breast cancer.S100A7 (psoriasin) influences immune response genes in human breast cancer.Estrogen receptor-beta regulates psoriasin (S100A7) in human breast cancer.Preferential estrogen receptor β ligands reduce Bcl-2 expression in hormone-resistant breast cancer cells to increase autophagy.Oncostatin M suppresses oestrogen receptor-α expression and is associated with poor outcome in human breast cancer.Reactive oxygen species induce phosphorylation of serine 118 and 167 on estrogen receptor alpha.
P50
Q21261220-EFA4B960-F2CA-44EB-B8D2-48817DB267EFQ21261243-42DEC613-9B10-44EB-B53A-4ACD3BCE801BQ22000741-9F9F691D-0C4D-4A7F-BC87-7710A8311CA8Q24293707-CDBE2FE8-065D-43D7-B04E-5373C12C49D2Q24645148-ABB0D85F-A73E-4B23-A2DE-1EDC2F6C5B5CQ24791098-D1B1E3DE-BB47-40F0-8CAC-FB41B6B8228BQ27001200-3E4F8B15-1710-4F17-B02F-21A31BB7FB37Q27025419-4C20750D-15C3-466B-B677-5EA959ACCD5FQ28397338-33DA8EE6-B824-49FD-B490-CFEA83B14E1DQ28656236-04E407F9-10C3-42BE-B2AF-E26F5CC985DBQ33827011-773FC781-4D80-475E-86BD-1C79B5DBE3C6Q34332592-0317BBE7-3F6A-4811-8E1E-B7FAAF926A82Q34337425-FD7923EF-85ED-40A1-A5FE-D90E9323E032Q34631186-3E2092EB-7C18-4003-AB3A-42DB12F673B0Q34747887-A58191CD-240D-45BF-94ED-BDEB2628357DQ34794245-B600CE89-7891-44B1-BB87-157EDAC0BE43Q34854883-768EAFCB-BA1F-4722-BF46-BE6CBF301D63Q35622050-43138164-62A3-4AC8-BAEA-BA380618508BQ36251310-3D6450A4-EF67-4EE2-A96B-7BAA1BF3DE36Q36477512-F094C8EC-762D-47F0-8357-34E6D3554C60Q36489866-DD240DC7-018E-41DF-889A-DE253F0608A2Q36612259-0092D402-59DE-4E1D-BA53-8553CDA0BC2FQ36617807-6DEB0852-55C2-4776-814D-0608FFCA2492Q36618787-D7B81302-1D83-47E6-B915-353BE56F7775Q36646462-4077F696-94E2-45F2-BB4E-6ACDE7BAE864Q36648304-CE265608-F44F-4FF0-9A14-7DCC70C13083Q36683460-DA61CCA2-1467-43DE-A9BB-1E9AEF9429FCQ37075185-DAE31590-5EED-4E33-A7AE-EC32113F6426Q37467175-A5D192BB-3668-4997-960B-78050A0FB792Q37476202-4BE99D42-9620-4B8C-BDF6-F505A5881591Q37796937-E872AAA1-E94A-4CCC-B890-ECD7D2F24240Q37819658-B70471BA-22D5-4F1B-9804-F8B20E279CEAQ37978223-51AB2D91-F255-4984-8EB2-ABE6F4DA265BQ38213171-2ADD70DE-F91C-4808-BCCC-3111EE50A781Q38268994-99A39652-0FA1-4D2B-ABAF-1AD04460CE9DQ38300967-93227ECB-ECEE-4732-8796-CA086FFDF214Q38309065-4B9181A1-FF1D-41EA-988F-321B0FFD0732Q38999879-601EE4EC-4F38-4EB5-955C-9071751936E4Q39407980-155C775D-8D5A-43C8-AB91-131F9B40DBDEQ39926596-9D8A0C51-275A-492A-A3ED-A324933CACF4
P50
description
Australian oncologist
@en
Australian oncologist
@en-ca
Australian oncologist
@en-gb
oncóloga australiana
@es
طبيبة أورام أسترالية
@ar
name
Leigh C Murphy
@nl
Leigh C Murphy
@sl
Leigh C. Murphy
@en
Leigh C. Murphy
@ga
Leigh C. Murphy
@sq
Leigh Murphy
@ca
Leigh Murphy
@es
Leigh Murphy
@fr
type
label
Leigh C Murphy
@nl
Leigh C Murphy
@sl
Leigh C. Murphy
@en
Leigh C. Murphy
@ga
Leigh C. Murphy
@sq
Leigh Murphy
@ca
Leigh Murphy
@es
Leigh Murphy
@fr
altLabel
Leigh Murphy
@en
prefLabel
Leigh C Murphy
@nl
Leigh C Murphy
@sl
Leigh C. Murphy
@en
Leigh C. Murphy
@ga
Leigh C. Murphy
@sq
Leigh Murphy
@ca
Leigh Murphy
@es
Leigh Murphy
@fr
P1153
7201572408
P21
P27
P31
P496
0000-0002-7676-6032